oxxa23: "...we're now 4.5 months into Paul wearing an MD hat for PAR and interim CEO of NSB.... I struggle to see...."
oxxa23/others holding/buying PAR: "oxxa23" I know as a poster on another HC thread. Sorry to all here for my posting, as I am NEITHER a holder of PAR nor of NSB ! However, I have followed NSB for quite some time now, I was (and am) always interested in any company that is trying to tackle the terrible disease of AD....
But back to "oxxa23's" remark about Paul being the interim CEO of NSB at the same as wearing the MD hat for PAR. I can assure you that - at least in my view (and I could be wrong but doubt it) - Paul does spend precious little time on NSB, which is not going well at all for certain. Hence, his focus is most certainly rather on PAR (but from what I am reading here, he might also be a bit slow to advance matters 'with purpose' here).
Wishing you PAR holders/buyers only the very best. Seems like PAR has great technology and "only" needs someone able to sell that with purpose.
Enjoy your Easter break.
wasa
- Forums
- ASX - By Stock
- PAR
- Webinar - 6.30am tomorrow
Webinar - 6.30am tomorrow, page-51
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 0.225 |
5 | 44676 | 0.220 |
7 | 82313 | 0.215 |
13 | 181424 | 0.210 |
8 | 128042 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 131244 | 5 |
0.245 | 56918 | 2 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online